Mass General Brigham Gene and Cell Therapy researchers present key findings at ASGCT
Meeting Announcement
Leaders and investigators from the Mass General Brigham Gene and Cell Therapy Institute, a hub of innovation dedicated to accelerating groundbreaking research, conducting clinical trials and developing FDA-approved treatments in gene and cell therapy, will present at the 2024 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting, held May 7-11, in Baltimore.
The University of Copenhagen is excited to announce Aging as a Tier 5 Sponsor of the 11th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 26 - August 30, 2024 on-site at the Ceremonial Hall, University of Copenhagen, and online.
The University of Copenhagen is excited to announce OneSkin as Tier 5 Sponsor of the 11th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 26 - August 30, 2024 on-site at the Ceremonial Hall, University of Copenhagen, and online.
The University of Copenhagen is excited to announce Altos Labs as a Tier 5 Sponsor of the 11th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 26 - August 30, 2024 on-site at the Ceremonial Hall, University of Copenhagen, and online.
During SCAI 2024 Scientific Sessions, the Society for Cardiovascular Angiography & Interventions (SCAI) presented its "30 in Their 30’s" award to thirty early-career interventional cardiologists.
James B. Hermiller, MD, MSCAI, director of the Interventional Cardiology Fellowship and the Structural Heart Program at St. Vincent Ascension Heart Center in Indianapolis, IN, assumed the office of president of the Society for Cardiovascular Angiography & Interventions (SCAI) today during the closing ceremonies at the SCAI 2024 Scientific Sessions in Long Beach, CA.
Interventional cardiology's future success relies on a diverse workforce that will help to positively impact patient outcomes. Now in its second year, SCAI’s Ready to Launch program introduces the interventional cardiology field to a diverse group of medical students at all levels, providing hands-on experience and mentorship opportunities. The program is hosted annually during SCAI Scientific Sessions with participation from local medical schools.